Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
S2023-056-01
Phase 2 small_molecule completed
Quick answer
Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor for Acute Myeloid Leukemia is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed